AC Immune SA (ACIU)
2.925
+0.06
(+2.27%)
USD |
NASDAQ |
Aug 25, 14:04
AC Immune Total Assets (Quarterly) : 186.45M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 186.45M |
| March 31, 2026 | 171.02M |
| December 31, 2025 | 194.70M |
| September 30, 2025 | 215.68M |
| June 30, 2025 | 238.97M |
| March 31, 2025 | 238.58M |
| December 31, 2024 | 254.80M |
| September 30, 2024 | 289.55M |
| June 30, 2024 | 264.34M |
| March 31, 2024 | 185.72M |
| December 31, 2023 | 217.21M |
| September 30, 2023 | 156.30M |
| June 30, 2023 | 174.62M |
| March 31, 2023 | 185.16M |
| December 31, 2022 | 200.97M |
| September 30, 2022 | 208.85M |
| June 30, 2022 | 226.44M |
| March 31, 2022 | 255.93M |
| December 31, 2021 | 286.94M |
| September 30, 2021 | 218.04M |
| June 30, 2021 | 228.37M |
| March 31, 2021 | 242.21M |
| December 31, 2020 | 270.08M |
| Date | Value |
|---|---|
| September 30, 2020 | 279.30M |
| June 30, 2020 | 288.38M |
| March 31, 2020 | 297.90M |
| December 31, 2019 | 309.03M |
| September 30, 2019 | 316.25M |
| June 30, 2019 | 303.82M |
| March 31, 2019 | 314.18M |
| December 31, 2018 | 199.39M |
| September 30, 2018 | 213.68M |
| June 30, 2018 | 113.36M |
| March 31, 2018 | 125.33M |
| December 31, 2017 | 135.47M |
| September 30, 2017 | 129.64M |
| June 30, 2017 | 137.09M |
| March 31, 2017 | 144.46M |
| December 31, 2016 | 153.59M |
| September 30, 2016 | 165.76M |
| June 30, 2016 | 106.02M |
| March 31, 2016 | 76.80M |
| December 31, 2015 | 79.85M |
| September 30, 2015 | 56.43M |
| June 30, 2015 | 37.43M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| BeOne Medicines Ltd. | 9.176B |
| CRISPR Therapeutics AG | 2.651B |
| Idorsia Ltd. | 575.13M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 142.85M |
| Shareholders Equity (Quarterly) | 43.60M |
| Debt to Equity Ratio | 0.1166 |
| Current Ratio | 0.9318 |
| Net Debt Paydown Yield | 0.07% |